Stimulation of mucosal immunity by pulmonary delivery of live vaccines. A safe and effective strategy against TB
|
|
- Gavin Brown
- 5 years ago
- Views:
Transcription
1 Les Diablerets, 3rd February 2016 Stimulation of mucosal immunity by pulmonary delivery of live vaccines. A safe and effective strategy against TB Nacho Aguilo (naguilo@unizar.es)
2 Live TB Vaccine TB infection MIMIC NATURAL ROUTE OF INFECTION INDUCE STRONG SPECIFIC MUCOSAL RESPONSE IN THE SITE OF INFECTION
3 ANIMAL MODELS TESTED WITH PULMONARY LIVE VACCINES Goonetilleke et al Tree et al Chen et al Giri et al Aguilo et al Lagranderie et al Kaushal et al. 2015
4 SAFETY DATA OF BCG PULMONARY VACCINATION IN PRECLINICAL MODELS Tree et al Lagranderie et al Pulmonary vaccination with live vaccines is safe in preclinical models
5 Weekly BCG doses of 3x10 7 by the aerosol route No hepatic or pulmonary toxicity was doccumented during the study
6 EFFICACY DATA IN ANIMAL MODELS Guinea Pigs LogCFUs aerosol subcutaneous Lagranderie et al Tubercle and Lung Disease
7 EFFICACY DATA IN ANIMAL MODELS Balb/c mice Lihao Chen et al Infection and Immunity
8 EFFICACY DATA IN ANIMAL MODELS C57BL/6 mice 0.71 log 1.3 log 1.8 log Aguilo et al Clinical Vaccine Immunology
9 EFFICACY DATA IN ANIMAL MODELS C57BL/6 mice Dose response profile in BCG pulmonary vaccination ns * ** * Aguilo et al Clinical Vaccine Immunology
10 RE-VACCINATION OF BCG SC-IMMUNIZED MICE WITH BCG IN BCG IN boosts BCG SC vaccination * Unpublished results
11 Does pulmonary BCG work where parenteral immunization fails?
12 LogCFUs subcutaneous Parenteral BCG immunization confers good protection in preclinical models used to test TB vaccines
13 DBA/2 MOUSE STRAIN TB susceptible and resistant mouse strains Medina et al Immunology
14 DBA/2 MOUSE STRAIN BCG subcutaneous poorly protects DBA/2 mice against TB challenge Medina et al Immunology Gruppo et al Microbiology
15 PROTECTIVE EFFICACY (CFU in lungs) 8 weeks 4 weeks s.c. BCG Danish 10 6 CFUS i.n. Challenge H37Rv 150 CFUS Sacrifice ns BCG s.c does not confer protection to DBA/2 mice Aguilo et al. Journal of Infectious Diseases. IN PRESS
16 PROTECTIVE EFFICACY (CFU in lungs and spleen) 8 weeks 4 weeks s.c. or i.n BCG Danish 10 6 CFUS i.n. Challenge H37Rv 150 CFUS Sacrifice ** ** BCG i.n confers protection to DBA/2 mice in lungs and spleen Aguilo et al. Journal of Infectious Diseases. IN PRESS
17 PROTECTIVE EFFICACY (Survival) 8 weeks Survival s.c. or i.n BCG Danish 10 6 CFUS i.n. Challenge H37Rv 1000 CFUS Aguilo et al. Journal of Infectious Diseases. IN PRESS
18 IMMUNOGENECITY PRE-CHALLENGE 8 weeks s.c. or i.n BCG Danish 10 6 CFUS PPD-specific immune response Lung Spleen ** IFNg ** BCG intranasal induces both local and systemic higher Th1 and Th17 IL17A Aguilo et al. Journal of Infectious Diseases. IN PRESS
19 IMMUNOGENECITY POST-CHALLENGE 8 weeks 4 weeks s.c. or i.n BCG Danish 10 6 CFUS i.n. Challenge H37Rv 150 CFUS Sacrifice: CFUs and PPD-specific immune response PPD-specific immunity CFUs Aguilo et al. Journal of Infectious Diseases. IN PRESS
20 IMMUNOGENECITY POST-CHALLENGE challenge * * Th17 lung response postchallenge correlates with better protection p=0.02 challenge Aguilo et al. Journal of Infectious Diseases. IN PRESS
21 ROLE OF IL17A IN PROTECTIVE EFFICACY ail17a treatment (clone 17F3) 8 weeks 4 weeks s.c. or i.n BCG Danish 10 6 CFUS - i.n. Challenge H37Rv 150 CFUS - PPD-specific immune response Sacrifice ** IL17A contributes to protection mediated by BCG intranasal ** Aguilo et al Journal of Infectious Diseases. IN PRESS
22 Johansen et al Mucosal Immunology MUCOSAL IMMUNOGLOBULINS (IgA)
23 pigr FUNCTION WT pigr -/- Johansen et al Journal of Experimental Medicine
24 Achkar et al ROLE OF IgA IN PROTECTIVE EFFICACY
25 IgA INDUCTION BY BCG IN BAL Induction of MTB-specific IgA by BCG intranasal in an IL17-dependent fashion ** ** ** 120 kda 100 kda pigr ** Aguilo et al. Journal of Infectious Diseases. IN PRESS
26 PROTECTION AND IgA INDUCTION BY HEAT-KILLED MTB BAL SAMPLES ** Unpublished results
27 SUMMARY Good safety profile of live pulmonary vaccines in different preclinical models. Pulmonary route of administration is more effective than parenteral vaccination in animal models. Pulmonary vaccination can work where parenteral immunization fails. Possible role of IL17 in BCG pulmonary-induced protection. Good correlation of specific IgA in BAL with protection
28 Grupo de Genética de Micobacterias Nacho Aguiló José Antonio Aínsa* Henar Alonso Esther Broset Alberto Cebollada Ana Belén Gómez Jesús Gonzalo Begoña Grácia Mª José Iglesias Gozalo* Carmen Lafoz Elena Mata Raquel Tarancón * IP coordinadores de línea Carlos Lampreave Dessi Marinova Isabel Otal* Ana Pico Sofía Samper * Luis Solans Santiago Uranga Samuel Álvarez Liliana Rodrigues Irene Perez Microbiología Clínica Mª José Revillo Pinilla Asunción Vitoria Dirección General de Salud Pública Grupo de Apoptosis, Inmunidad y Cancer Alberto Anel Julian Pardo Centro de Encefalopatías y Enfermedades Emergentes Marta Monzón Juan J Badiola
29
TBVI Symposium Les Diablerets 2 nd February Updates on Vaccine Candidates & Clinical Development Strategies MTBVAC.
TBVI Symposium Les Diablerets 2 nd February 2017 Updates on Vaccine Candidates & Clinical Development Strategies MTBVAC Carlos Martín GLOBAL TRANSMISSION of Mycobacterium tuberculosis LINEAGES IN HUMANS
More informationTBVI Symposium TB Vaccines and Immunity MTBVAC, an update
TBVI Symposium TB Vaccines and Immunity MTBVAC, an update Eugenia Puentes, Biofabri Annual TBVAC 2020 Meeting, 1 st 5 th February 2016, Les Diablerets CONSTRUCTION OF MTBVAC Derived from a clinical isolate
More informationRUTI: a new therapeutic vaccine to shorten the latent tuberculosis infection treatment
RUTI: a new therapeutic vaccine to shorten the latent tuberculosis infection treatment Authors: Cristina Vilaplana, Sergio Pinto, Eva Montané, Mahavir Singh, Vicenç Ausina, Joan Costa, Pere-Joan Cardona
More informationExperiment #1 TARGET Mouse Model Group. Report prepared by Paul Converse, Ph.D. and Eric Nuermberger, M.D. March 1, 2006
Protocol for in vivo evaluation of growth rates and pathogenesis of M. tuberculosis strains found to have rapid or slow growth phenotypes in an in vitro model Experiment #1 TARGET Mouse Model Group Report
More informationMonitoring tuberculosis progression using MRI and stereology
Monitoring tuberculosis progression using MRI and stereology TB the problem Estimated number of new cases in 2007 2 million deaths; 9 million new cases p.a. TB kills someone every 15 secs, 9,153 cases
More informationPaucibacillary Tuberculosis in Mice after Prior Aerosol Immunization with Mycobacterium bovis BCG
INFECTION AND IMMUNITY, Feb. 2004, p. 1065 1071 Vol. 72, No. 2 0019-9567/04/$08.00 0 DOI: 10.1128/IAI.72.2.1065 1071.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved. Paucibacillary
More informationThe non-human primate model in TB vaccine development
April 10, 2015 The non-human primate model in TB vaccine development Tom Evans MD Aeras Agenda Issues Transmission studies Recent advancements Outcomes Endpoint analysis Design Going forward 2 Development
More informationJornada sobre INVESTIGACIÓN CLÍNICA EN PEDIATRÍA. Cristina Calvo Hospital Universitario La Paz
Jornada sobre INVESTIGACIÓN CLÍNICA EN PEDIATRÍA Cristina Calvo Hospital Universitario La Paz INDEX 1. Research structure 1. Clinical Trials Unit 2. Pediatric Research Groups 2. Research Networks 3 RESEARCH
More informationIL-22 mediates mucosal host defense against gram negative bacterial pneumonia
IL-22 mediates mucosal host defense against gram negative bacterial pneumonia Shean J. Aujla, Yvonne R. Chan, Mingquan Zheng, Mingjian Fei, David J. Askew, Derek A. Pociask,Todd A. Reinhart, Florencia
More informationVPM1002 A new TB prime vaccine on the horizon Leander Grode Project Manager/ Director BD
VPM1002 A new TB prime vaccine on the horizon Leander Grode Project Manager/ Director BD Vakzine Projekt Management GmbH Mellendorfer Str. 9 D-30625 Hannover Telephone: +49 511 169908 0 grode(at)vakzine-manager.de
More informationEffect of oral exposure of Mycobacterium avium intracellular on the protective immunity induced by BCG
J. Biosci., Vol. 10, Number 4, December 1986, pp. 453-460. Printed in India. Effect of oral exposure of Mycobacterium avium intracellular on the protective immunity induced by BCG SUJATHA NARAYANAN, C.
More informationGlobal progress in vaccine development
Global progress in vaccine development Helen McShane The Jenner Institute University of Oxford helen.mcshane@ndm.ox.ac.uk Vaccination The most cost-effective health intervention Smallpox Poliomyelitis
More informationANONYMOUS UNLINKED STUDY OF THE PREVALENCE OF ANTI- HIV ANTIBODIES IN MOTHERS OF LIVE NEWBORNS FROM 6 AUTONOMOUS REGIONS
SECRETARÍA GENERAL DE SANIDAD DIRECCIÓN GENERAL DE SALUD PÚBLICA Y SANIDAD EXTERIOR ANONYMOUS UNLINKED STUDY OF THE PREVALENCE OF ANTI- HIV ANTIBODIES IN MOTHERS OF LIVE NEWBORNS FROM 6 AUTONOMOUS REGIONS
More informationSummary. Keywords: attenuated live vaccines, tuberculosis, two component system, virulence. Introduction
Clinical and Experimental Immunology ORIGINAL ARTICLE doi:1.1111/j.1365-2249.6.3284.x Immunological responses and protective immunity against tuberculosis conferred by vaccination of Balb/C mice with the
More informationIncreased efficacy of chemotherapy against Mycobacterium tuberculosis by additive immunotherapy using a multistage MVA vaccine
February 22 nd, 218 Increased efficacy of chemotherapy against Mycobacterium tuberculosis by additive immunotherapy using a multistage MVA vaccine Vaccine Candidates for Tuberculosis TRANSGENE PRIORITY
More informationAnnual report. Biomédica
Annual report Biomédica Journal of the Volume 37, 2017 EDITORIAL BOARD EDITORS Luis Alberto Gómez Carlos Arturo Hernández Rubén Santiago Nicholls Emeritus Researcher Pan American Health Organization Brasilia,
More informationPerspectives on Clinical and Preclinical Testing of New Tuberculosis Vaccines
CLINICAL MICROBIOLOGY REVIEWS, Oct. 2010, p. 781 794 Vol. 23, No. 4 0893-8512/10/$12.00 doi:10.1128/cmr.00005-10 Copyright 2010, American Society for Microbiology. All Rights Reserved. Perspectives on
More informationMemory NK cells during mousepox infection. Min Fang, Ph.D, Professor Institute of Microbiology, Chinese Academy of Science
Memory NK cells during mousepox infection Min Fang, Ph.D, Professor Institute of Microbiology, Chinese Academy of Science Infectious Diseases are a Major Cause of Death Worldwide May 14 th 1796 Prevalence
More informationFinal published version:
Boosting BCG-primed responses with a subunit Apa vaccine during the waning phase improves immunity and imparts protection against Mycobacterium tuberculosis Subhadra Nandakumar, Centers for Disease Control
More informationAspirin antagonism in isonizaid treatment of tuberculosis in mice ACCEPTED. Department of Molecular Microbiology & Immunology, Bloomberg School of
AAC Accepts, published online ahead of print on 4 December 2006 Antimicrob. Agents Chemother. doi:10.1128/aac.01145-06 Copyright 2006, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationShigella Pathogenesis and Vaccine Development
Shigella Pathogenesis and Vaccine Development Ryan Ranallo, Ph.D. Department of Enteric Infections Division of Communicable Diseases and Immunology Walter Reed Army Institute of Research Causes of Travelers
More informationHeat-killed Lactobacillus casei
Heat-killed Lactobacillus casei confers broad protection against influenza A virus primary infection and develops heterosubtypic immunity against future secondary infection Yu-Jin Jung, Young-Tae Lee,
More informationMichael Santosuosso, Sarah McCormick, Xizhong Zhang, Anna Zganiacz, and Zhou Xing*
INFECTION AND IMMUNITY, Aug. 2006, p. 4634 4643 Vol. 74, No. 8 0019-9567/06/$08.00 0 doi:10.1128/iai.00517-06 Copyright 2006, American Society for Microbiology. All Rights Reserved. Intranasal Boosting
More informationPerspective in novel TB vaccine development Mohamed Ridha BARBOUCHE M.D., Ph.D. Department of Immunology Institut Pasteur de Tunis
Perspective in novel TB vaccine development Mohamed Ridha BARBOUCHE M.D., Ph.D. Department of Immunology Institut Pasteur de Tunis Existing TB Vaccine is not effective for global TB epidemic control BCG
More informationDose response relationships for Listeria monocytogenes in ready-to-eat foods
Dose response relationships for Listeria monocytogenes in ready-to-eat foods Roland Lindqvist 5th ASEPT International Conference of risk analysis and Listeria monocytogenes March 17-18, 2004 LAVAL - France
More informationReceived 29 April 2008/Returned for modification 23 June 2008/Accepted 26 October 2008
INFECTION AND IMMUNITY, Jan. 2009, p. 223 231 Vol. 77, No. 1 0019-9567/09/$08.00 0 doi:10.1128/iai.00526-08 Copyright 2009, American Society for Microbiology. All Rights Reserved. Immunogenicity and Protective
More informationExosomes function in antigen presentation during an in vivo Mycobacterium tuberculosis infection
Exosomes function in antigen presentation during an in vivo Mycobacterium tuberculosis infection Victoria L. Smith, Yong Cheng, Barry R. Bryant and Jeffrey S. Schorey Supplementary Figure 1: Unprocessed
More informationLD 60 determinations.-in order to study the resistance of mice to H. RESISTANCE INDUCED AGAINST HISTOPLASMA CAPSULA TUM: QUANTITATIVE ASPECTS*
RESISTANCE INDUCED AGAINST HISTOPLASMA CAPSULA TUM: QUANTITATIVE ASPECTS* GILBERT A. HILLt AND STANLEY MARCUS From the Department of Bacteriology, College of Medicine, University of Utah, Salt Lake City
More informationImmunologically Induced and Elicited Local
INFECTION AND IMMUNITY, Dec. 1970, p. 757-761 Copyright 1970 American Society for Microbiology Vol. 2, No. 6 Printed in U.S.A. Immunologically Induced and Elicited Local Resistance to Staphylococcus aureus
More informationMUCOSAL AdHu5Ag85A VACCINE-INDUCED B CELL IMMUNITY AGAINST TUBERCULOSIS
MUCOSAL AdHu5Ag85A VACCINE-INDUCED B CELL IMMUNITY AGAINST TUBERCULOSIS i THE ROLE OF B CELLS IN RESPIRATORY MUCOSAL AdHu5Ag85A VACCINE-INDUCED IMMUNITY AGAINST TUBERCULOSIS By AMANDEEP KHERA, B.Sc. A
More informationTBVI the European Tuberculosis Vaccine Ininiative. Brigitte GICQUEL INSTITUT PASTEUR
TBVI the European Tuberculosis Vaccine Ininiative Brigitte GICQUEL INSTITUT PASTEUR Moving towards a TB free world in 2050 Foundation to facilitate European efforts Foundation to facilitate European efforts
More informationImmunology 2011 Lecture 11 Innate Immunity & Genetics of Inbreeding. 6 October
Immunology 2011 Lecture 11 Innate Immunity & Genetics of Inbreeding 6 October HANDOUT #6, Problem Set 3 TODAY Innate Immunity no core notes Genetics of Inbreeding - Appendix 10 MHC & Transplantation, Chapter
More informationTB Vaccine Research and Development: Progress, Strategies and Controversies
15 March 2016 GVIRF Global Forum Johannesburg, South Africa TB Vaccine Research and Development: Progress, Strategies and Controversies Lewis Schrager, M.D. V.P., Scientific Affairs Rockville, MD USA Source:
More informationWith the Presidency of Her Majesty the Queen Sofia
ay, 21 st 10:00-15:00 Welcome and registration. Posters set-up With the Presidency of Her Majesty the Queen Sofia 12:00-12:15 OFFICIAL OPENING 12:15-13:15 KEYNOTE LECTURE Introduced by: Jesús Ávila. Bengt
More informationII Congreso Internacional de Investigación e Innovación en Enfermedades Neurodegenerativas (CIIIEN)
II Congreso Internacional de Investigación e Innovación en Enfermedades Neurodegenerativas (CIIIEN) II International Congress on Research and Innovation in Neurodegenerative Diseases X Simposio Internacional:
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,900 116,000 120M Open access books available International authors and editors Downloads Our
More informationThe mouse cholera toxin model for evaluation of allergenicity
The mouse cholera toxin model for evaluation of allergenicity Joost Smit, ILSI 2012 Of mice and men.(mestas, J Immunol 2004; 172:2731) Mouse Human Neutrophils in blood 10-25% 50-70% Lymphocytes in blood
More informationWANTED Manuscript supporting the prevailing paradigm of tuberculosis by any author DEAD or ALIVE $1,000 REWARD. 3 TB India HSCP
A New Paradigm for the Pathogenesis of Pulmonary Tuberculosis Bronchogenic tuberculosis The missing link between primary and post-primary disease Robert Hunter MD, PhD Dept. of Pathology and Laboratory
More informationTargeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacy
Received 7 Apr 6 Accepted 8 v 6 Published Dec 6 DOI:.8/ncomms89 OPEN Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacy Kristin L. Griffiths,
More information21-23 ALICANTE INTERNATIONAL CONGRESS ON RESEARCH AND INNOVATION IN NEURODEGENERATIVE DISEASES CONGRESO INTERNACIONAL
IV IV ALICANTE 2016 VENUE: european union intellectual property office Avenida de Europa, 4, E-03008 Alicante, España. INTERNATIONAL CONGRESS ON RESEARCH AND INNOVATION IN NEURODEGENERATIVE DISEASES CONGRESO
More informationIN VIVO STUDIES ON VIRAL VIRULENCE
IN VIVO STUDIES ON VIRAL VIRULENCE M.Phil student: Emily TSUI Supervisor: Professor Paul K.S Chan Department of Microbiology, CUHK Date: 15th Dec, 2014 Viral Virulence Capacity of a virus to cause disease
More information21-23 CONGRESO INTERNACIONAL DE INVESTIGACIÓN E INNOVACIÓN EN ENFERMEDADES NEURODEGENERATIVAS CONGRESS
IV CONGRESO INTERNACIONAL DE INVESTIGACIÓN E INNOVACIÓN EN ENFERMEDADES NEURODEGENERATIVAS IV INTERNATIONAL ON RESEARCH AND INNOVATION IN IVNEURODEGENERATIVE DISEASES IV CONGRESS ALICANTE 2016 Septiembre
More informationImmune evasion and identification of biomarkers associated with mycobacterial infection
Licentiate thesis from the Department of Immunology, Wenner-Gren Institute, Stockholm University, Sweden Immune evasion and identification of biomarkers associated with mycobacterial infection John Arko-Mensah
More informationSirturo: a new treatment against multidrug resistant tuberculosis
Sirturo: a new treatment against multidrug resistant tuberculosis TB is an on-going problem WHO estimated incidence of new TB cases 2009 Global Tuberculosis Control: WHO report 2010. Available at: http://www.who.int/tb/publications/global_report/2010/en/index.html
More informationMucosal and Parenteral Vaccination against Acute and Latent Murine Cytomegalovirus (MCMV) Infection by Using an Attenuated MCMV Mutant
JOURNAL OF VIROLOGY, Jan. 1998, p. 442 451 Vol. 72, No. 1 0022-538X/98/$04.00 0 Copyright 1998, American Society for Microbiology Mucosal and Parenteral Vaccination against Acute and Latent Murine Cytomegalovirus
More informationSupplementary Material
Supplementary Material Supplementary Figure 1. NOS2 -/- mice develop an analogous Ghon complex after infection in the ear dermis and show dissemination of Mtb to the lung. (A) WT and NOS2 -/- mice were
More informationImmunity to Bodetella pertussis. Kingston Mills. Trinity Biomedical Sciences Institute Trinity College Dublin, Ireland
Immunity to Bodetella pertussis Kingston Mills Trinity Biomedical Sciences Institute Trinity College Dublin, Ireland Correlates / mechanisms of immunity Vaccine/ Infection Efficacy in Children Efficacy
More informationIn uence of BCG vaccine strain on the immune response and protection against tuberculosis
REVIEW ARTICLE In uence of BCG vaccine strain on the immune response and protection against tuberculosis Nicole Ritz 1,2,3, Willem A. Hanekom 4, Roy Robins-Browne 2,5, Warwick J. Britton 6 & Nigel Curtis
More informationCardiovascular Diseases (BMM9) and Getting to Know CNIC course Course
Cardiovascular Diseases (BMM9) and Getting to Know CNIC course Course 2013-2014 A. Lectures: 13-30 January (09:30-12:15 h) I. Form and function of the cardiovascular system (13-15 January) 13 January (09.30
More informationInfection. This information is current as of August 19, 2018.
This information is current as of August 19, 2018. Supplementary Material References Blockade of IL-10 Signaling during Bacillus Calmette-Guérin Vaccination Enhances and Sustains Th1, Th17, and Innate
More informationA Multicistronic DNA Vaccine Induces Significant Protection against Tuberculosis in Mice and Offers Flexibility in the Expressed Antigen Repertoire.
Company LOGO A Multicistronic DNA Vaccine Induces Significant Protection against Tuberculosis in Mice and Offers Flexibility in the Expressed Antigen Repertoire. Fayaz Ahmad Mir, Stefan H. E. Kaufmann,
More informationZheng, BJ; Du, LY; Zhao, GY; Lin, YP; Sui, HY; Chan, C; Ma, S; Guan, Y; Yuen, KY. Citation Hong Kong Medical Journal, 2008, v. 14 suppl. 4, p.
Title Studies of SARS virus vaccines Author(s) Zheng, BJ; Du, LY; Zhao, GY; Lin, YP; Sui, HY; Chan, C; Ma, S; Guan, Y; Yuen, KY Citation Hong Kong Medical Journal, 2008, v. 14 suppl. 4, p. 39-43 Issued
More informationStudying Repeated Immunization in an Animal Model. Kanta Subbarao Laboratory of Infectious Diseases, NIAID
Studying Repeated Immunization in an Animal Model Kanta Subbarao Laboratory of Infectious Diseases, NIAID Animal models in Influenza Research Commonly used Mice Ferrets Guinea pigs Non human primates Less
More informationIMMUNOTOOLS: EFFECT OF NOTCH-DEFICIENT MACROPHAGES TO AUTOIMMUNE DISEASE WIPAWEE WONGCHANA
IMMUNOTOOLS: EFFECT OF NOTCH-DEFICIENT MACROPHAGES TO AUTOIMMUNE DISEASE 22-02-2017 WIPAWEE WONGCHANA WHAT DO YOU SEE? Allergy Ref: http://carrington.edu/blog/medical/vaccines/smallpox-andsmallpox-vaccine/
More informationDevelopment of VPM1002/rBCG urec::hly Tuberculosis vaccine
eine Initiative des Bundesministeriums für Bildung und Forschung (BMBF) Development of VPM1002/rBCG urec::hly Tuberculosis vaccine Bernd Eisele M.D. CEO Vakzine Projekt Management GmbH eisele(at)vakzine-manager.de
More informationEnhanced Cancer Vaccine Effectiveness with NKTR-214, a CD122-Biased Cytokine
Enhanced Cancer Vaccine Effectiveness with NKTR-214, a CD122-Biased Cytokine Jonathan Zalevsky SVP, Biology and Preclinical Development Nektar Therapeutics SMI Cancer Vaccines, September 2017 Nektar Therapeutics
More informationTB-VAC. An integrated project for the design and testing of vaccine candidates against tuberculosis: identification, development, and clinical studies
TB-VAC An integrated project for the design and testing of vaccine candidates against tuberculosis: identification, development, and clinical studies Tuberculosis-a worldwide problem 30 % of the world
More informationImmunogenicity and Protective Effect of Inactivated M.
INFECTION AND IMMUNITY, Apr. 1977, p. 88-92 Copyright C 1977 American Society for Microbiology Vol. 16, No. 1 Printed in U.S.A. Immunoprophylaxis of Experimental Mycoplasma pneumoniae Disease: Effect of
More informationABIMMUNE Repurposing disused antibiotics with immune modulators as antimicrobial strategy for respiratory tract infections
ABIMMUNE Repurposing disused antibiotics with immune modulators as antimicrobial strategy for respiratory tract infections Jean-Claude Sirard Christophe Carnoy Fiordiligie Casilag Delphine Cayet The partners
More information! " *+*,+-./+,.- 0+ "
! " #$%&'(() *+*,+-./+,.- 0+ " 1 1. Introduction BCG vaccine is the only vaccine currently available for immunization against tuberculosis (TB) infections and has been used since the 1920s. During this
More informationVI IMPLANTOLOGY SYMPOSIUM
VI IMPLANTOLOGY Seville. 8 th February 2019 Implantology in its purest state at Hotel Silken Al Andalus Palace SOMETIMES A ZERO IS THE BEST MARK YOU CAN GET Ticare features GAP 0, the first connection
More informationTECHNICAL BULLETIN. INFORCE 3: Prevents respiratory disease caused by bovine respiratory syncytial virus. INF January 2016
INF-00017 TECHNICAL BULLETIN January 2016 INFORCE 3: Prevents respiratory disease caused by bovine respiratory syncytial virus. Zoetis 100 Campus Drive Florham Park, New Jersey 07932 SUMMARY Two vaccination/challenge
More informationMedical Bacteriology- Lecture 10. Mycobacterium. Actinomycetes. Nocardia
Medical Bacteriology- Lecture 10 Mycobacterium Actinomycetes Nocardia 1 Mycobacterium Characteristics - Large, very weakly gram positive rods - Obligate aerobes, related to Actinomycetes - Catalase positive
More informationSupplementary Figure 1. NAFL enhanced immunity of other vaccines (a) An over-the-counter, hand-held non-ablative fractional laser (NAFL).
Supplementary Figure 1. NAFL enhanced immunity of other vaccines (a) An over-the-counter, hand-held non-ablative fractional laser (NAFL). (b) Depiction of a MTZ array generated by NAFL. (c-e) IgG production
More informationMECHANISMS OF ATTENUATION AND PROTECTION OF MTBVAC: a live attenuated TB vaccine moving to clinical efficacy trials in endemic countries
Breakout Session 3: Novel Vaccine Concepts and reclinical Research Thursday, 22 February 2018 MECHANISMS F ATTENUATIN AND RTECTIN F MTBVAC: a live attenuated TB vaccine moving to clinical efficacy trials
More informationMedical Bacteriology- lecture 13. Mycobacterium Actinomycetes
Medical Bacteriology- lecture 13 Mycobacterium Actinomycetes Mycobacterium tuberculosis Large, very weakly gram positive rods, Obligate aerobes, related to Actinomycetes, non spore forming, non motile
More informationIncreased levels of immunological markers in the respiratory tract but not in serum correlate with active pulmonary mycobacterial infection in mice
ORIGINAL ARTICLE 1.1111/j.1469-691.29.2734.x Increased levels of immunological markers in the respiratory tract but not in serum correlate with active pulmonary mycobacterial infection in mice J. Arko-Mensah
More informationExercise Alters Stress and Inflammatory Response in Lungs of Mice
Exercise Alters Stress and Inflammatory Response in Lungs of Mice Joseph Sevcik1, Shibani Naik2, Marian L Kohut1,2 1Department of Kinesiology, Iowa State University, Ames, IA 2Immunobiology Department,
More informationAdaptive Immunity to Bacteria. T cell subsets
Adaptive Immunity to Bacteria Role of T cells in anti-bacterial host responses. Dr. C. Piccirillo Department of Microbiology & Immunology McGill University T cell subsets MHC I and II -restricted cells
More informationCD101: A Novel Echinocandin
CD101: A Novel Echinocandin Taylor Sandison, MD MPH Chief Medical Officer TIMM Belgrade, Serbia October 8, 2017 1 Disclosures Dr. Sandison is an employee of and stockholder in Cidara Therapeutics 2 Cidara
More informationFundamentals of Tuberculosis (TB)
TB in the United States Fundamentals of Tuberculosis (TB) From 1953 to 1984, reported cases decreased by approximately 5.6% each year From 1985 to 1992, reported cases increased by 20% 25,313 cases reported
More informationStrategies for making vaccines efficacious in the elderly
Strategies for making vaccines efficacious in the elderly Rino Rappuoli Ageing and Immunity Siena April 22 nd 2012 Ageing is good Ageing is most often framed in negative terms. Questioning whether health
More informationTransmissibility, virulence and fitness of resistant strains of M. tuberculosis. CHIANG Chen-Yuan MD, MPH, DrPhilos
Transmissibility, virulence and fitness of resistant strains of M. tuberculosis CHIANG Chen-Yuan MD, MPH, DrPhilos Transmissibility, Virulence and Fitness of resistant strains of M. tuberculosis For infectious
More informationENYGO REPORT. Summary
ENYGO REPORT Summary The first ENYGO Workshop on Fertility Sparing in Gynaecological Oncology was held at La Paz University Hospital in Madrid (Spain) from 27 to 28 January 2017. It was a very successful
More informationTrends in vaccinology
Trends in vaccinology Mathieu Peeters, MD Joint Conference of European Human Pharmacological Societies and Joint Conference of European Human Pharmacological Societies and 20th Anniversary of AGAH March
More informationSponsored document from Microbes and Infection / Institut Pasteur
Sponsored document from Microbes and Infection / Institut Pasteur The Syk/CARD9-coupled receptor Dectin-1 is not required for host resistance to Mycobacterium tuberculosis in mice Mohlopheni J. Marakalala
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/35908 holds various files of this Leiden University dissertation Author: Soema, Peter Title: Formulation of influenza T cell peptides : in search of a universal
More information24 26 January 2013, Hong Kong SAR, CHINA. TITLE from VIEW and SLIDE MASTER February 27, 2013
The first WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses 24 26 January 2013, Hong Kong SAR, CHINA 1 TITLE
More informationNature Medicine: doi: /nm.4322
1 2 3 4 5 6 7 8 9 10 11 Supplementary Figure 1. Predicted RNA structure of 3 UTR and sequence alignment of deleted nucleotides. (a) Predicted RNA secondary structure of ZIKV 3 UTR. The stem-loop structure
More informationMalaria parasite vaccine development Strategies & Targets
Malaria parasite vaccine development Strategies & Targets Tulane University Ahmed Aly Most malaria disease deaths are among children and pregnant women A child or a pregnant woman dies of malaria nearly
More informationBiomédica Journal of the Instituto Nacional de Salud Volume 34, 2014
Biomédica Journal of the Volume 34, 2014 EDITORIAL BOARD Luis Alberto Gómez Carlos Arturo Hernández Rubén Santiago Nicholls Emeritus Researcher Pan American Health Organization Brasilia, Brazil Enrique
More informationImmunity to Influenza in Ferrets
INFECTION ANI) IMMUNITY. June 1974. 1). 985-99) Copyright ( 1974 American Society for Microbiology Vol. 9. No. 6 Printed in U.S.A. Immunity to Influenza in Ferrets X. Intranasal Immunization of Ferrets
More informationComparative immunogenicity of fowl cholera vaccine in Jinding ducks
The Bangladesh Veterinarian (2013) 30(2) : 41-45 Comparative immunogenicity of fowl cholera vaccine in Jinding ducks S Sultana, S Saha and MM Amin* 1 Department of Microbiology and Hygiene, Faculty of
More informationCancer Vaccines and Combination Immunotherapy
Cancer Vaccines and Combination Immunotherapy Bernard A. Fox, PhD Harder Family Chair for Cancer Research Member and Chief, Laboratory of Molecular and Tumor Immunology Earle A. Chiles Research Institute
More informationApplication of New Diagnostics and Preventative Treatment in Low and High Burden Settings
Application of New Diagnostics and Preventative Treatment in Low and High Burden Settings Edward Nardell, MD Brigham & Women s Hospital Harvard Medical School Partners In Health Disclosures opps! Served
More informationon Infectivity of Air on a Hospital Ward
Materials for Online Data Supplement for AJRCCM Surgical Face Masks Worn by Patients with Multidrug-Resistant Tuberculosis: Impact on Infectivity of Air on a Hospital Ward Authors: Ashwin S. Dharmadhikari
More informationJiangping Li 1,2 Jun Zhao 1 Juan Shen 1 Changyou Wu 1 Jie Liu 2. Abstract 1 INTRODUCTION ORIGINAL ARTICLE
Received: 13 May 2018 Revised: 20 September 2018 Accepted: 23 September 2018 DOI: 10.1111/jcmm.13965 ORIGINAL ARTICLE Intranasal immunization with Mycobacterium tuberculosis Rv3615c induces sustained adaptive
More informationImmunobiology, BIOL 537 Spring 2013
Immunobiology, BIOL 537 Spring 2013 Instructor: Dr. Elliott Blumenthal Office: Science Building, # 390 Class Meets: 6:00-7:15 PM TR Phone: 481-6004 E-mail: Blumenth@ipfw.edu SB 168 481-6305 (Biology Office)
More informationanys. Reinfection vs. Reactivation Is this the question?
Reinfection vs. Reactivation Is this the question? Unitary Concept. Stead 1967. Infant and Adult TB is defined as Primary and Post-primary as a conclusion of the mass radiography campaings in Europe after
More informationPREPARATION STANDARD MATERIAL HELD AT CODE WHO/BS DOCUMENT. 1st Reference Reagent, 2009
WHO International Biological Reference Preparations Held and Distributed by the WHO International Laboratories for Biological Standards Acellular pertussis vaccine for potency assay by modified mouse challenge
More informationARTICLE IL-17-dependent SIgA-mediated protection against nasal Bordetella pertussis infection by live attenuated BPZE1 vaccine
www.nature.com/mi ARTICLE IL-17-dependent SIgA-mediated protection against nasal Bordetella pertussis infection by live attenuated BPZE1 vaccine Luis Solans 1,2,3,4, Anne-Sophie Debrie 1,2,3,4, Lisa Borkner
More informationOncologist. The. Symptom Management and Supportive Care
The Oncologist Symptom Management and Supportive Care Randomized Crossover Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Granisetron in Cancer Patients Treated with Platinum-Based Chemotherapy
More informationNew Tuberculosis Guidelines. Jason Stout, MD, MHS
New Tuberculosis Guidelines Jason Stout, MD, MHS Two New Sets of Guidelines Treatment of Drug-Susceptible Tuberculosis Clinical Infectious Diseases 2016; 63(7): e147-e195 Diagnosis of Tuberculosis in Adults
More informationVeterinary Tuberculosis Vaccine Development
S223 Veterinary Tuberculosis Vaccine Development J. Frank T. Griffin From the Division of Immunology, Department of Microbiology, University of Otago, Dunedin, New Zealand Tuberculosis caused by Mycobacterium
More informationFoot and Mouth Disease Vaccine Research and Development in India
Foot and Mouth Disease Vaccine Research and Development in India R.Venkataramanan Indian Veterinary Research Institute, Hebbal, Bangalore 560 024 Foot and Mouth Disease in India Present Status Large Susceptible
More informationEffect of 24 Week Intensification with a CCR5-Antagonist on the Decay of the HIV-1 Latent Reservoir
Effect of 24 Week Intensification with a CCR5-Antagonist on the Decay of the HIV-1 Latent Reservoir Laura Díaz 1, Carolina Gutiérrez 2, Carmen Page 2, Raquel Lorente 1, Beatriz Hernández-Novoa 2, Alejandro
More informationVaccinology 101 for Fellows
Vaccinology 101 for Fellows Meg Fisher, MD Medical Director, The Children s Hospital Monmouth Medical Center An affiliate of the Saint Barnabas Health Care System Long Branch, NJ Disclosures I have no
More informationREGULATION OF GRANULOMA FORMATION IN MURINE MODELS OF TUBERCULOSIS. Holly Marie Scott. Bachelors of Science, Mount Union College, 1998
REGULATION OF GRANULOMA FORMATION IN MURINE MODELS OF TUBERCULOSIS by Holly Marie Scott Bachelors of Science, Mount Union College, 1998 Submitted to the Graduate Faculty of School of Medicine in partial
More informationEffect of Vaccine, Route, and Schedule on Antibody
APPUED MICROBIOLOGY, Mar. 1969, p. 355-359 Copyright 1969 American Society for Microbiology Vol. 17, No. 3 Printed in U.S.A. Effect of Vaccine, Route, and Schedule on Antibody Response of Rabbits to Pasteurella
More information